Sohn Conference: Raising the red flag on drug makers

4:51 AM ET Tue, 3 Oct 2017

Richard Marshaal, Senvest Management founder and CEO, who oversees about $1.5 billion in assets, explains why he thinks shares of Insys Therapeutics could sell off.